Aberrant Expression of KOR-SA3544 Antigen in Childhood Acute Lymphoblastic Leukemia Predicts TEL-AML1 Negativity

Leukemia - United Kingdom
doi 10.1038/sj.leu.2401072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

TEL-AML1 Positivity in Relapsed B Cell Precursor Acute Lymphoblastic Leukemia in Childhood

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Origins of "Late" Relapse in Childhood Acute Lymphoblastic Leukemia With TEL-AML1 Fusion Genes

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Impact of TEL/AML1-positive Patients on Age Distribution of Childhood Acute Lymphoblastic Leukemia in Czech Republic

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Quantitative Analysis of TEL/AML1 Fusion Transcripts by Real-Time RT-PCR Assay in Childhood Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Childhood Acute Lymphoblastic Leukemia

Oncologist
Cancer ResearchMedicineOncology
1997English

The KOR-SA3544 Antigen Predominantly Expressed on the Surface of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Cells Is Nonspecific Cross-Reacting Antigen-50/90 (CD66c) and Invariably Expressed in Cytoplasm of Human Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2019English

Expression of ZNF695 Transcript Variants in Childhood B-Cell Acute Lymphoblastic Leukemia

Genes
Genetics
2019English

Nutritional Considerations in Childhood Acute Lymphoblastic Leukemia

Cancer and Oncology Research
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy